Management of glycemia in critically ill patients;Prise en charge de la glycémie du patient en état critique

Reanimation

Volumn 11, Issue 6, 2002, Pages 421-425

  Devos, Ph ^a   Preiser, J C ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Service des Soins Intensifs   (Belgium)

Author keywords

Brain infarction; Carbohydrates; Heart infarction; Infection; Insulin

Indexed keywords

GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOXANE A2; VASODILATOR AGENT;

CLINICAL FEATURE; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HORMONAL REGULATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MEDIATOR; MORBIDITY; MORTALITY; REVIEW; STATISTICAL SIGNIFICANCE; STRESS;

EID: 0036758733     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(02)00270-0     Document Type: Short Survey

References (39)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345: 1359-67.
2. McCowen KC, Malhotra A, Bristrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-24.
3. Avignon A, Monnier L. Insulinosensibilité et situation de stress. Diabetes Metab 2001; 27: 233-8.
4. Mizock BA. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533-51.
5. Mizock BA. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98: 75-84.
6. Daley JM, Shearer JD, Caldwell MD. Glucose metabolism in injured tissue: A longitudinal study. Surgery 1990; 107: 187-92.
7. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, et al. Differentiation between septic and postburn insulin resistance. Metabolism 1989; 38: 983-9.
8. Fan J, Li YH, Wojnar MM. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor IRS 1, and MAP kinase in skeletal muscle. Shock 1996; 6: 164-70.
9. Wolfe RR, Jahoor F, Herndon DN. Isotopic evaluation of the metabolism of pyruvate and related substrate in normal adult volunteers and severely burn children: Effect of dichloroacetate and glucose infusion. Surgery 1991; 110: 54-67.
10. Virkamaki A, Yki-Jarvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 1994; 134: 2072-8.
11. Fietsam RJ, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg 1991; 57: 551-7.
12. Pozzilli P, Leslie RD. Infections and diabetes: Mechanisms and prospects for prevention. Diabet Med 1994; 11: 935-41.
13. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: 540-4.
14. Mowlavi A, Andrews K, Milner S, Herdon DR, Heggers JP, et al. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 2000; 45: 629-32.
15. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-60.
16. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356-61.
17. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999; 88: 1011-6.
18. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo S, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. J Parenter Enteral Nutr 1997; 21: 91-5.
19. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989; 38: 1031-5.
20. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus. FEMS Immunol Med Microbiol 1999; 26: 259-65.
21. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: The case for glucose control. Am J Med 1982; 72: 439-50.
22. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulins. J Trauma 1990; 30: 830-2.
23. Hostetter MK, Lorenz JS, Preus L, Kendrick KE. The iC3b receptor on Candida albicans: Subcellular localization and modulation of receptor expression by glucose. J Infect Dis 1990; 161: 761-8.
24. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229: 11-8.
25. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-8.
26. Bolk J, van der Ploeg T, Cornel JH, Arnold E, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79: 207-14.
27. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction study. Circulation 1999; 99: 2626-32.
28. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-31.
29. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A, et al. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 1998; 28: 687-94.
30. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-701.
31. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32: 2426-32.
32. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001; 58: 1209-12.
33. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS, et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The glucose insulin in stroke trial. Stroke 1999; 304: 793-9.
34. Sieber FE, Traystman RJ. Special issues: Glucose and the brain. Crit Care Med 1992; 20: 104-14.
35. Bruno A, Biller J, Adams HPJ, Clarke WR, Woolson RF, Williams LS. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52: 280-4.
36. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46: 335-42.
37. Schurr A, Payne RS, Tseng MT, Miller JJ, Iyre V. The glucose paradox in cerebral ischemia. New insights. Ann NY Acad Sci 1999; 893: 386-430.
38. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995; 82: 262-8.
39. Voll CL, Whishaw IQ, Auer RN. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. Stroke 1989; 20: 646-51.